Duchenne Muscular Dystrophy is the most common form of muscular dystrophy, occurring in approximately 1 in 5,000 male births. Currently there is no cure for Duchenne and the diagnosis is terminal, devastating the lives of many young boys and their families every year. Those affected with Duchenne lose their ability to walk, feed themselves, breathe independently and eventually succumb to heart failure.

Fortunately, we are closer than ever in the race to find a cure and save the next generation from a life with Duchenne. While we believe that it is important to support patient welfare today, we know that by funding the pioneering research, critical clinical trials and developments in assistive technology we will actively participate towards a better tomorrow for Duchenne boys globally. Together we can make history.